Cargando…

Cerebrospinal Fluid Levels of Chromogranin A in Parkinson’s Disease and Multiple System Atrophy

Background: Chromogranin A (CgA) and other peptides from the chromogranin–secretogranin family have been recently studied as potential biomarkers of various neurodegenerative diseases, including Parkinson’s disease (PD). Methods: We measured CgA in the cerebrospinal fluid (CSF) of 119 PD patients, 1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaiserova, Michaela, Chudackova, Monika, Mensikova, Katerina, Vastik, Miroslav, Kurcova, Sandra, Prikrylova Vranova, Hana, Stejskal, David, Kanovsky, Petr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912438/ https://www.ncbi.nlm.nih.gov/pubmed/33499181 http://dx.doi.org/10.3390/brainsci11020141

Ejemplares similares

Deep Brain Stimulation Effects on Gait Pattern in Advanced Parkinson’s Disease Patients
por: Navratilova, Daniela, et al.
Publicado: (2020)

Familial atypical parkinsonism with rare variant in VPS35 and FBXO7 genes: A case report
por: Bartonikova, Tereza, et al.
Publicado: (2016)

Bilateral subthalamic deep brain stimulation initial impact on nonmotor and motor symptoms in Parkinson's disease: An open prospective single institution study
por: Kurcova, Sandra, et al.
Publicado: (2018)

Case Report: Concomitant Alzheimer's and Lewy-Related Pathology Extending the Spectrum of Underlying Pathologies of Corticobasal Syndrome
por: Kaiserová, Michaela, et al.
Publicado: (2021)

New endemic familial parkinsonism in south Moravia, Czech Republic and its genetical background
por: Bartoníková, Tereza, et al.
Publicado: (2018)

Lewy body disease or diseases with Lewy bodies?
por: Menšíková, Kateřina, et al.
Publicado: (2022)

Reply: Matters Arising ‘Lewy body disease or diseases with Lewy bodies?’
por: Menšíková, Kateřina, et al.
Publicado: (2022)

Biomarkers of Neurodegenerative Diseases: Biology, Taxonomy, Clinical Relevance, and Current Research Status
por: Koníčková, Dorota, et al.
Publicado: (2022)

Unusual phenotype of pathologically confirmed progressive supranuclear palsy with autonomic dysfunction and cerebellar ataxia: Case report
por: Mensikova, Katerina, et al.
Publicado: (2016)

Whole Exome Sequencing Study in Isolated South-Eastern Moravia (Czechia) Population Indicates Heterogenous Genetic Background for Parkinsonism Development
por: Kolarikova, Kristyna, et al.
Publicado: (2022)

Cerebrospinal Fluid Metabolome in Parkinson’s Disease and Multiple System Atrophy
por: Kwon, Do Hyeon, et al.
Publicado: (2022)

PART and ARTAG tauopathies at a relatively young age as a concomitant finding in sporadic Creutzfeldt-Jakob disease
por: Menšíková, Kateřina, et al.
Publicado: (2021)

High-Throughput Sequencing Haplotype Analysis Indicates in LRRK2 Gene a Potential Risk Factor for Endemic Parkinsonism in Southeastern Moravia, Czech Republic
por: Kolarikova, Kristyna, et al.
Publicado: (2022)

MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson’s Disease and Multiple System Atrophy
por: Marques, Tainá M., et al.
Publicado: (2016)

Cerebrospinal Fluid Biomarkers in Multiple System Atrophy Relative to Parkinson's Disease: A Meta-Analysis
por: Xie, Dan, et al.
Publicado: (2021)

Botulinum toxin injection changes resting state cerebellar connectivity in cervical dystonia
por: Hok, Pavel, et al.
Publicado: (2021)

Hippocampal subfield atrophy in relation to cerebrospinal fluid biomarkers and cognition in early Parkinson’s disease: a cross-sectional study
por: Stav, Ane Løvli, et al.
Publicado: (2016)

Metabolomic investigations in cerebrospinal fluid of Parkinson's disease
por: Willkommen, Desiree, et al.
Publicado: (2018)

Serum but not cerebrospinal fluid levels of allantoin are increased in de novo Parkinson’s disease
por: Hasíková, Lenka, et al.
Publicado: (2023)

Chromogranin A in the Laboratory Diagnosis of Pheochromocytoma and Paraganglioma
por: Bílek, Radovan, et al.
Publicado: (2019)

Atrophy, metabolism and cognition in the posterior cortical atrophy spectrum based on Alzheimer's disease cerebrospinal fluid biomarkers
por: Montembeault, Maxime, et al.
Publicado: (2018)

Ceruloplasmin functional changes in Parkinson’s disease-cerebrospinal fluid
por: Barbariga, Marco, et al.
Publicado: (2015)

Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease
por: Hall, Sara, et al.
Publicado: (2016)

Blood and Cerebrospinal Fluid Biomarkers of Inflammation in Parkinson’s Disease
por: Zimmermann, Milan, et al.
Publicado: (2022)

Glial fibrillary acidic protein in cerebrospinal fluid of patients with spinal muscular atrophy
por: Freigang, Maren, et al.
Publicado: (2022)

Cerebrospinal fluid characteristics of patients treated with intrathecal nusinersen for spinal muscular atrophy
por: Orbach, Rotem, et al.
Publicado: (2022)

Cerebrospinal Fluid Proteomic Changes after Nusinersen in Patients with Spinal Muscular Atrophy
por: Beaudin, Marie, et al.
Publicado: (2023)

Low Efficacy of Chromogranin A Elimination by Therapeutic Plasma Exchange for Treatment of Chromogranin A Tubulopathy
por: Hakroush, Samy, et al.
Publicado: (2021)

Cytokinin Plant Hormones Have Neuroprotective Activity in In Vitro Models of Parkinson’s Disease
por: Gonzalez, Gabriel, et al.
Publicado: (2021)

Oxidative Stress Markers in Cerebrospinal Fluid of Newly Diagnosed Multiple Sclerosis Patients and Their Link to Iron Deposition and Atrophy
por: Burgetova, Andrea, et al.
Publicado: (2022)

Determination of chitinase 3-like 1 in cerebrospinal fluid in multiple sclerosis and other neurological diseases
por: Kušnierová, Pavlína, et al.
Publicado: (2020)

Cerebrospinal Fluid Lysosomal Enzymes and Alpha-Synuclein in Parkinson's Disease
por: Parnetti, Lucilla, et al.
Publicado: (2014)

Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease
por: Schröder, Jens B., et al.
Publicado: (2018)

Cerebrospinal fluid proteomics implicates the granin family in Parkinson’s disease
por: Rotunno, Melissa S., et al.
Publicado: (2020)

Cerebrospinal Fluid Cytokines and Neurodegeneration‐Associated Proteins in Parkinson's Disease
por: Wijeyekoon, Ruwani S., et al.
Publicado: (2020)

Imaging protein aggregates in the serum and cerebrospinal fluid in Parkinson’s disease
por: Lobanova, Evgeniia, et al.
Publicado: (2021)

Lipid Metabolism Disorder in Cerebrospinal Fluid Related to Parkinson’s Disease
por: Qiu, Jiewen, et al.
Publicado: (2023)

Cerebrospinal fluid volumetric MRI mapping as a simple measurement for evaluating brain atrophy
por: De Vis, J. B., et al.
Publicado: (2015)

Cerebrospinal fluid neurofilament light concentration predicts brain atrophy and cognition in Alzheimer's disease
por: Dhiman, Kunal, et al.
Publicado: (2020)

The relationship between myodural bridge, atrophy and hyperplasia of the suboccipital musculature, and cerebrospinal fluid dynamics
por: Yang, Heng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_co02inglaocol0iorm881rr44q